Jonathan D. Oakley
Acceleron Pharma (United States)(US)
Publications by Year
Research Areas
Retinal Imaging and Analysis, Glaucoma and retinal disorders, Retinal and Optic Conditions, Retinal Diseases and Treatments, Optical Coherence Tomography Applications
Most-Cited Works
- → Macular Ganglion Cell–Inner Plexiform Layer: Automated Detection and Thickness Reproducibility with Spectral Domain–Optical Coherence Tomography in Glaucoma(2011)421 cited
- → Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis(2011)342 cited
- → Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography(2011)330 cited
- → Ability of Cirrus HD-OCT Optic Nerve Head Parameters to Discriminate Normal from Glaucomatous Eyes(2010)327 cited
- → Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness(2011)286 cited
- → Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning(2012)233 cited
- → Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis(2013)225 cited
- → Deep Learning for Prediction of AMD Progression: A Pilot Study(2019)101 cited
- → In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques(2012)87 cited
- → Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis(2017)58 cited